期刊文献+

5-Fu、MTX、VP16-213联合方案治疗恶性妊娠滋养细胞肿瘤的研究 被引量:2

5-Fu、MTX、VP16-213 Regime in the treatment of gestational trophoblastic tumor.
下载PDF
导出
摘要 目的 探讨 5 -Fu、MTX、VP16 - 2 13联合化学治疗恶性妊娠滋养细胞肿瘤患者的疗效。方法 对1992年 4月至 2 0 0 3年 4月 11年本院 91例恶性妊娠滋养细胞肿瘤 (包括侵蚀性葡萄胎和绒癌 )患者采用 5 -Fu、MTX、VP16 - 2 13三联化疗方案治疗 ,其中绒癌 36例 ,有 2例为复发性绒癌 ;侵蚀性葡萄胎 (侵葡 ) 5 5例。Ⅰ期 16例 ,Ⅱ期 2 6例 ,Ⅲ期 5 6例。结果  91例患者中 ,采用此三联化疗方案治疗有 86例获治愈 ,总治愈率高达 94 5 1%。此三联化疗方案的主要毒副反应是骨髓抑制和胃肠道反应 ,其中Ⅲ~Ⅳ度粒细胞减少占2 7 3% ,Ⅲ~Ⅳ度血小板减少占 7 4 % ,Ⅲ度恶心呕吐占 19 8% ,Ⅲ度腹泻占 2 4 % ,Ⅰ度肝功损害占 2 1% ,在 19 6 9%的疗程中发生口腔溃疡 ,其中Ⅲ度占 8 36 %。结论  5 -Fu、MTX、VP16 - 2 13联合方案治疗恶性妊娠滋养细胞肿瘤可达满意的临床效果 。 Objective To discuss the application of the regime combining 5-Fu、MTX with VP16-213 in treatment of gestational trophoblastic tumor.Methods A total of 91 cases of gestational trophoblastic neoplasm treated by 5-Fu、MTX、VP16-213 regime during the period of April, 1992 to April, 2003 at the First Hospital of Xi'an Jiaotong University was retrospectively analyzed. Results Eighty six of the total 91 cases which were treated by the consociated regimen has been completely cured, with 94.51% healing rate. On the other hand,this regimen has the side-effect of marrow suppression and gastric intestinal disorder, and of all, there are 27.3% granulocytopenia of Ⅲ~Ⅳ degree, 7.4% thrombocytopenia of Ⅲ~Ⅳ degree, severe nausea and vomiting of 19.8%,severe diarrhea of 3.4%, liver dysfunction of 2.1%,19.69% oral ulcer in which about 8.36% are Ⅲ degree ones.Conclusion Offered to the cases of gestationa1 trophoblastic neoplasm, the alliance regime of 5-Fu、MTX、VP16-213 could get the satisfied clinical effect, and could reach good results for the chemotherapy resistant or recurrent cases.
出处 《现代肿瘤医学》 CAS 2004年第2期103-105,共3页 Journal of Modern Oncology
关键词 恶性妊娠滋养细胞肿瘤 联合化疗 毒副反应 绒毛膜癌 侵蚀性葡萄胎 choripcarcinoma invasive mole chemotherapy gestational trophoblastic tumor
  • 相关文献

参考文献2

  • 1万希润,杨秀玉.恶性滋养细胞肿瘤的化学疗法[J].中国实用妇科与产科杂志,2001,17(7):398-400. 被引量:14
  • 2世界卫生组织(WHO).抗肿瘤药物急性及亚急性毒性反应分度标准[A].孙燕.内科肿瘤学[C].北京:人民卫生出版社,2001.905.

二级参考文献2

  • 1Newlands E S,J Reprod Med,1998年,43卷,2期,111页
  • 2Bakri Y N,Gynecol Oncol,1993年,48卷,1期,110页

共引文献14

同被引文献22

  • 1宋水勤,张国楠.BEP方案治疗恶性滋养细胞肿瘤38例临床分析[J].中国妇产科临床杂志,2006,7(4):248-250. 被引量:16
  • 2王晶,谢守珍,连俊红.化疗联合甲羟孕酮治疗侵蚀性葡萄胎与绒毛膜癌的疗效观察[J].医药导报,2006,25(9):897-899. 被引量:4
  • 3Wong L C, Ngan H Y,Cheng D K,et al. Methotrexate Infusion in Low-risk Gestational Trophoblastic Disease[J].Am J Obstet Gynecol,2000,183(6) : 1579-1582.
  • 4Turan T,Karacay O,Tulunay G,et al. Results with EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cycluphosphamide,Vincristine)Chemotherapy in Gestational Truphoblastic Neoplasia[J]. Int J Gynecol Cancer, 2006,16(3) : 1432-1438.
  • 5Rustin G J, Newlands E S, Lutz J M, et al. Combination but not Single-agent Methotrexate Chemotherapy for Gestational Trophoblastie Tumors Increases the Incidence of Second Tumors[J]. J Clin Oncol,1996,14(10) :2769-2777.
  • 6El Lamie I K,El Sayed H M,Badawie A G,et al. Evolution of Treatment of High-risk Metastatic Gestational Trophoblastic Tumors: Ain Shams University Experience[J].Int J Gynecol Cancer,2006,16(2):866-874.
  • 7Wan X,Xing Y,Yang X,et al. Efficacy of the FAEV Regimen in the Treatment of High-risk, Drug-resistant Gestational Trophoblastic Tumor[J]. J Reprod Med, 2007,52 (10) : 941- 944.
  • 8Osborne R,Covens A, Mirchandani D, et al. Successful Salvage of Relapsed High-risk Gestational Trophoblastic Neoplasia Patients Using a Novel Paclitaxel-containing Doublet [J]. J Reprod Med,2004,49(8) :655-661.
  • 9Carlini L,Villa A,Busci L,et al. Selective Uterine Artery Embolization: a New Therapeutic Approach in a Patient with Low-risk Gestational Trophoblastic Disease[J]. Am J Ohstet Gynecol, 2006,195(1) :314-315.
  • 10Lok C A,Reekers J A,Westermann A M,et al. Embolization for Hemorrhage of Liver Metastases from Choriocarcinoma[J].Gynecol Oncol,2005,98(3):506-509.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部